TipRanks
Go Ultimate55% OFF

SD Biosensor, Inc. (137310) Stock Price & Analysis

137310 Stock Chart & Stats

$6,340.00$60.00(0.96%)
At close: 3:30 PM GMT+9
$6,000$6,250$6,500$6,7503 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$6,200.00 - $6,390.00
52-Week Range
$5,800.00 - $10,060.00
Previous Close
$6,280.00
Volume
N/A
Average Volume (3M)
116.72K
Market Cap
KRW 752.05B
Enterprise Value
KRW 646.14B
Total Cash (Recent Filing)
KRW 408.07B
Total Debt (Recent Filing)
KRW 285.11B
Price to Earnings (P/E)
―
Beta
0.06
Next Earnings
Nov 16, 2026 (Est.)
EPS Estimate
N/A
Dividend Yield
3.15%

Bulls Say, Bears Say

Bulls Say

Revenue Stabilization

The meaningful TTM revenue rebound after the 2023 decline indicates that demand and commercial activity have begun to stabilize. If maintained, renewed top-line growth could improve operating leverage and provide a stronger foundation for recovering profitability over the next several quarters.

Manageable Leverage

Improving debt-to-equity and moderate overall leverage give SD Biosensor greater financial flexibility while it works through weak earnings. A sizable equity base can help absorb continued volatility and preserve capacity to support operations without relying excessively on additional borrowing.

Prior Cash Flow Recovery

The return to positive operating and free cash flow in 2024 and 2025 shows that the business has demonstrated an ability to convert operations into internally generated liquidity. That recovery can support funding needs and reduce dependence on external capital if cash generation remains durable.

Bears Say

Sustained Losses

Persistent losses across 2023 through TTM indicate that the revenue rebound has not yet translated into sustainable earnings. Widening TTM losses can consume equity over time, restrict reinvestment capacity, and make the company more vulnerable if operating conditions remain challenging.

Margin Compression

Repeated gross-margin compression suggests that incremental revenue is currently producing less economic value than in earlier periods. Unless margins stabilize, weaker unit economics will limit operating leverage, constrain future profit recovery, and make sustained earnings improvement more difficult.

Weaker Recent Cash Generation

The steep TTM decline in free cash flow reduces the liquidity cushion that had improved during 2024 and 2025. Weaker cash conversion relative to reported losses could limit internally funded investment and increase pressure on the balance sheet if the trend persists.

137310 FAQ

What was SD Biosensor, Inc.’s price range in the past 12 months?
SD Biosensor, Inc. lowest stock price was $5800.00 and its highest was $10060.00 in the past 12 months.
What is SD Biosensor, Inc.’s market cap?
SD Biosensor, Inc.’s market cap is ₩752.05B.
When is SD Biosensor, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SD Biosensor, Inc.’s earnings last quarter?
SD Biosensor, Inc. released its earnings results on Aug 14, 2026. The company reported $137.637 earnings per share for the quarter.
Is SD Biosensor, Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does SD Biosensor, Inc. pay dividends?
SD Biosensor, Inc. pays a ― dividend of $200 which represents an annual dividend yield of 3.15%. See more information on SD Biosensor, Inc. dividends here
What is SD Biosensor, Inc.’s EPS estimate?
SD Biosensor, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SD Biosensor, Inc. have?
SD Biosensor, Inc. has 120,749,100 shares outstanding.
What happened to SD Biosensor, Inc.’s price movement after its last earnings report?
SD Biosensor, Inc. reported an EPS of $137.637 in its last earnings report. Following the earnings report the stock price went up 0.614%.
Which hedge fund is a major shareholder of SD Biosensor, Inc.?
Currently, no hedge funds are holding shares in KR:137310
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology